Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease

BACKGROUND: Butyrate-producing gut bacteria are reduced in patients with active inflammatory bowel disease (IBD), supporting the hypothesis that butyrate supplementation may be beneficial in this setting. Nonetheless, earlier studies suggest that the oxidation of butyrate in IBD patients is altered....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Inflamm Bowel Dis
Egile Nagusiak: Ferrer-Picón, Elena, Dotti, Isabella, Corraliza, Ana M, Mayorgas, Aida, Esteller, Miriam, Perales, José Carlos, Ricart, Elena, Masamunt, Maria C, Carrasco, Anna, Tristán, Eva, Esteve, Maria, Salas, Azucena
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Original Basic Science Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6905302/
https://ncbi.nlm.nih.gov/pubmed/31211831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izz119
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak